Oncolytics Today Fall 2025
Published Date: April 22, 2025
Publication Highlights
7 | ONE BIG BEAUTIFUL BILL ACT: New reforms may not be so beautiful for oncology practices and patients
11 | BUSINESS BEHIND ONCOLOGY: Navigating payers, partnerships and the financial landscape
15 | ARTIFICIAL INTELLIGENCE: The near-term potential of AI remains shrouded in regulatory uncertainty
19 | DRUG PRICING UNDER IRA: New laws promise relief, but will pose a challenge for pharma and patients
23 | MEDICARE PART D MAZE: Education is the key to helping your patients understand the new rules
26 | A BETTER MODEL FOR ONCOLOGY: Experts make the case for expanding OOLD in preference to other distribution models
29 | NGS THERAPY REVIEW: The latest recommendations for NSCLC, colorectal, breast and prostate cancers
37 | THE CHALLENGE OF REMS: IMiD prescription management and the role of the pharmacist
43 | ADVANCES IN ALK INHIBITION: New therapies, resistance mechanisms and emerging strategies in NSCLC
50 | PROSTATE CANCER: Imaging and therapy options from an oncology perspective
54 | A NOVEL SCORING FRAMEWORK: Analyzing and improving access pathways to oral oncology therapies
57 | FINDING FINANCIAL ASSISTANCE: How PAN Foundation helps cancer patients
67-81 | INPATIENT TO OUTPATIENT: A look at how multiple practices are evolving CAR-T, BsAbs & BiTES therapy
76 | BsAbs RECOMMENDATIONS: Tear-out charts for lymphoma, multiple myeloma and other disease states
84 | PHARMACOGENOMICS: UCSF launches PGx program to enhance safety for gastrointestinal cancer patients
87 | ENHANCING ABIRATERONE: Case series on the effect of low-dose and low-fat diet on the drug’s cost and efficacy
93 | LOVE ON LIFE’S TERMS: Finding the language to support one another during the cancer journey
96 | RAPID TRIAL ACTIVATION: Implications and opportunities for investigational drug service operations
98 | CLINICAL TRIAL CHALLENGES: Improving enrollment through trust and patient-centric development
101-108 | GLOBAL PERSPECTIVE: International oncology reviews and reports from Brazil, Morocco and Japan
117 | THE ROAD WARRIOR: New Jersey pharmacist bike-a-thon rider goes that extra mile for his patients
To Request The Oncolytics Today Media Kit / Rate Card, Contact: partnership@ncoda.org
- Two issues in Spring (March) and Fall (October)
- Audience includes 10,000+ Oncology and Urology health professionals
- Print and digital formats available
- Multi-ad discounts available